RECRUITING

Implementing Virtual Reality (VR) to Reduce Sedation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study is a prospective pilot patients aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy. Patients are administered minimal sedation (2 mg of Versed and 25 mg of Fentanyl) and are given Virtual Reality (VR) goggles to wear for the duration of the procedure. The purpose of this study is to assess the feasibility, effect, and safety of using VR goggles during endoscopic procedures to decrease sedation requirements, enhance patient satisfaction, and reduce recovery time.

Official Title

Pilot Proof of Concept Study for Implementing Virtual Reality (VR) to Reduce Sedation Requirement During Endoscopy

Quick Facts

Study Start:2024-12-09
Study Completion:2026-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06349564

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Undergoing screening colonoscopy or diagnostic upper endoscopy for GERD or dyspepsia at NYU Langone Brooklyn Hospital
  2. * Aged 21 to 65
  1. * Visual impairments such as blindness which would impair them from watching the entertainment videos.
  2. * Patients with history of CAD,
  3. * History of seizures,
  4. * History of vertigo,
  5. * History of allergy to plastic,
  6. * ASAII or III,
  7. * Patient with active GI bleed, having either melena or hematochezia.

Contacts and Locations

Study Contact

Maysaa El Zoghbi, MD
CONTACT
216-835-7626
Maysaa.ElZoghbi@nyulangone.org
Jessica Rauch
CONTACT
332-268-0626
Jessica.rauch@nyulangone.org

Principal Investigator

Maysaa El Zoghbi, MD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Brooklyn
Brooklyn, New York, 11220
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Maysaa El Zoghbi, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-09
Study Completion Date2026-04

Study Record Updates

Study Start Date2024-12-09
Study Completion Date2026-04

Terms related to this study

Keywords Provided by Researchers

  • GERD
  • Dyspepsia
  • screening colonoscopy
  • diagnostic upper endoscopy
  • Gastroesophageal reflux disease

Additional Relevant MeSH Terms

  • Sedative During Endoscopy